Dyne Therapeutics, Inc. - COM (DYN)

Q3 2020 13F Holders as of 9/30/2020

Type / Class
Equity / COM
Number of holders
49
Total Shares
24.5M
Shares change
+24.5M
Total reported value, excl. options
$494M
Value change
+$494M
Put/Call ratio
0
Number of buys
49
Number of sells
0
Price
$20.19
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.